Immune Modulation and Immunotherapy in Solid Tumors: Mechanisms of Resistance and Potential Therapeutic Strategies DOI Open Access

Suman Giri,

Gopal Lamichhane, Jitendra Pandey

et al.

International Journal of Molecular Sciences, Journal Year: 2025, Volume and Issue: 26(7), P. 2923 - 2923

Published: March 24, 2025

Understanding the modulation of specific immune cells within tumor microenvironment (TME) offers new hope in cancer treatments, especially immunotherapies. In recent years, and resistance to immunotherapy have become critical challenges treatments. However, novel strategies for emerged as promising approaches oncology due vital roles immunomodulators regulating progression metastasis modulating immunological responses standard care With progress immuno-oncology, a growing number mechanisms are being uncovered, offering potential enhanced clinical near future. Thus, gaining comprehensive understanding broader context is essential. Herein, we particularly summarize paradoxical role tumor-related cells, focusing on how targeted their actions modulated by immunotherapies overcome immunotherapeutic cells. We also highlight molecular employed tumors evade long-term effects agents, rendering them ineffective.

Language: Английский

Digging Through the Complexities of Immunological Approaches in Emerging Osteosarcoma Therapeutics: A Comprehensive Narrative Review with Updated Clinical Trials DOI Creative Commons
Consolato Sergi,

Mervin Burnett,

Eugeniu Jantuan

et al.

Biomedicines, Journal Year: 2025, Volume and Issue: 13(3), P. 664 - 664

Published: March 8, 2025

Osteosarcoma (OS) is the predominant mesenchymal primary malignant bone tumor in oncology and pathology, impacting a wide age range from adolescents to older adults. It frequently advances lung metastasis, ultimately resulting mortality of OS patients. The precise pathological pathways responsible for progression dissemination are not fully understood due its heterogeneity. integration surgery with neoadjuvant postoperative chemotherapy has significantly increased 5-year survival rate more than 70% patients localized tumors. However, about 30% experience local recurrence and/or metastasis. Hence, there requirement innovative therapeutic approaches address limitations traditional treatments. Immunotherapy garnered increasing attention as promising avenue tumors resistant standard therapies, including OS, despite underlying mechanisms disease remaining well elucidated. may have been suitable use because tumor’s immunosuppressive microenvironment limited immunogenicity. Nevertheless, immune-based treatments now being developed clinical use, such bispecific antibodies, chimeric antigen receptor T cells, immune checkpoint inhibitors. Also, additional immunotherapy techniques cytokines, vaccines, modified-Natural Killer (NK) cells/macrophages early phases research but will certainly be popular subjects nearest future. Our goal writing this review was spark new lines inquiry into by summarizing findings both preclinical current studies examining different approaches.

Language: Английский

Citations

1

Turning cold into hot: emerging strategies to fire up the tumor microenvironment DOI
Kejing Ma, Lin Wang, Wenhui Li

et al.

Trends in cancer, Journal Year: 2024, Volume and Issue: unknown

Published: Dec. 1, 2024

Language: Английский

Citations

5

Recent innovations in machine learning for skin cancer lesion analysis and classification: A comprehensive analysis of computer‐aided diagnosis DOI Creative Commons
Syeda Shamaila Zareen, Md Shamim Hossain, Junsong Wang

et al.

Precision Medical Sciences, Journal Year: 2025, Volume and Issue: unknown

Published: Feb. 17, 2025

Abstract The global primary health concern of skin cancer emphasizes the need for quick and accurate diagnosis to improve patient outcomes. Although, it might be challenging evaluate possible risk a spot merely by looking at feeling it. This review article offers thorough overview current breakthroughs in machine learning (ML) computer‐aided diagnostics (CAD) aim analysis classification lesions over past 6 years. paper carefully reviews whole diagnostic process: data preparation, lesion segmentation, feature extraction, selection, final classification. Analyzed are many publicly accessible datasets creative ideas including deep (DL) ML integrated with computer vision, together their impact on increasing accuracy. Given variety complexity lesions, even enormous progress, there still major obstacles. rigorously assesses methods, notes areas great challenge, provides recommendations direct next research targeted improving early detection strategies CAD systems.

Language: Английский

Citations

0

Inflammation in Penile Squamous Cell Carcinoma: A Comprehensive Review DOI Open Access
Mateusz Czajkowski, Piotr Wierzbicki,

Maciej Dolny

et al.

International Journal of Molecular Sciences, Journal Year: 2025, Volume and Issue: 26(6), P. 2785 - 2785

Published: March 19, 2025

Inflammation appears to play a crucial role in the development and progression of penile cancer (PeCa). Two molecular pathways PeCa are currently described: HPV-dependent HPV-independent. The tumor immune microenvironment (TIME) is characterized by presence tumor-associated macrophages, cancer-associated fibroblasts, tumor-infiltrating lymphocytes. components TIME produce pro-inflammatory cytokines chemokines, which have been found be overexpressed tissues associated with unfavorable prognoses. Additionally, nuclear factor kappa B (NF-κB) pathway secreted phosphoprotein 1 (SPP1) implicated pathogenesis. Elevated C-reactive protein (CRP) levels neutrophil-to-lymphocyte ratio (NLR) identified as potential prognostic biomarkers PeCa. This overview presents complex contribution inflammatory process collates projects aimed at modulating

Language: Английский

Citations

0

Immune Modulation and Immunotherapy in Solid Tumors: Mechanisms of Resistance and Potential Therapeutic Strategies DOI Open Access

Suman Giri,

Gopal Lamichhane, Jitendra Pandey

et al.

International Journal of Molecular Sciences, Journal Year: 2025, Volume and Issue: 26(7), P. 2923 - 2923

Published: March 24, 2025

Understanding the modulation of specific immune cells within tumor microenvironment (TME) offers new hope in cancer treatments, especially immunotherapies. In recent years, and resistance to immunotherapy have become critical challenges treatments. However, novel strategies for emerged as promising approaches oncology due vital roles immunomodulators regulating progression metastasis modulating immunological responses standard care With progress immuno-oncology, a growing number mechanisms are being uncovered, offering potential enhanced clinical near future. Thus, gaining comprehensive understanding broader context is essential. Herein, we particularly summarize paradoxical role tumor-related cells, focusing on how targeted their actions modulated by immunotherapies overcome immunotherapeutic cells. We also highlight molecular employed tumors evade long-term effects agents, rendering them ineffective.

Language: Английский

Citations

0